Cargando…

2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms

The compound, 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside (TSG), a primary bioactive polyphenolic component of Polygonum multiflorum exerts numerous pharmacological activities. However, its protective effect against non-alcoholic steatohepatitis (NASH), in the context of metabolic syndrome, rema...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jin, Peng, Yi, Zeng, Yi, Hua, Yi-qiao, Xu, Xiao-le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479705/
https://www.ncbi.nlm.nih.gov/pubmed/30939745
http://dx.doi.org/10.3390/ijms20071617
_version_ 1783413406804475904
author Xu, Jin
Peng, Yi
Zeng, Yi
Hua, Yi-qiao
Xu, Xiao-le
author_facet Xu, Jin
Peng, Yi
Zeng, Yi
Hua, Yi-qiao
Xu, Xiao-le
author_sort Xu, Jin
collection PubMed
description The compound, 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside (TSG), a primary bioactive polyphenolic component of Polygonum multiflorum exerts numerous pharmacological activities. However, its protective effect against non-alcoholic steatohepatitis (NASH), in the context of metabolic syndrome, remains poorly understood. The aim of the present study is to evaluate the effects of TSG treatment on middle-aged (12-mo-old) male LDLr(−/−) mice, which were fed a high fat diet for 12 weeks to induce metabolic syndrome and NASH. At the end of the experiment, the blood samples of mice were collected for determination of metabolic parameters. Liver and aorta tissues were collected for analysis, such as histology, immunofluorescence, hepatic lipid content, real-time PCR, and western blot. Our data show that TSG treatment improved the different aspects of NASH (steatosis, inflammation, and fibrosis) and atherosclerosis, as well as some of the metabolic basal characteristics. These modulatory effects of TSG are mediated, at least in part, through regulating key regulators of lipid metabolism (SREBP1c, PPARα and their target genes, ABCG5 and CYP7A1), inflammation (CD68, TNF-α, IL-6 and ICAM), fibrosis (α-SMA and TNFβ) and oxidative stress (NADPH-oxidase 2/4, CYP2E1 and antioxidant enzymes). These results suggest that TSG may be a promising candidate for preventing and treating the progression of NASH.
format Online
Article
Text
id pubmed-6479705
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64797052019-04-29 2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms Xu, Jin Peng, Yi Zeng, Yi Hua, Yi-qiao Xu, Xiao-le Int J Mol Sci Article The compound, 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside (TSG), a primary bioactive polyphenolic component of Polygonum multiflorum exerts numerous pharmacological activities. However, its protective effect against non-alcoholic steatohepatitis (NASH), in the context of metabolic syndrome, remains poorly understood. The aim of the present study is to evaluate the effects of TSG treatment on middle-aged (12-mo-old) male LDLr(−/−) mice, which were fed a high fat diet for 12 weeks to induce metabolic syndrome and NASH. At the end of the experiment, the blood samples of mice were collected for determination of metabolic parameters. Liver and aorta tissues were collected for analysis, such as histology, immunofluorescence, hepatic lipid content, real-time PCR, and western blot. Our data show that TSG treatment improved the different aspects of NASH (steatosis, inflammation, and fibrosis) and atherosclerosis, as well as some of the metabolic basal characteristics. These modulatory effects of TSG are mediated, at least in part, through regulating key regulators of lipid metabolism (SREBP1c, PPARα and their target genes, ABCG5 and CYP7A1), inflammation (CD68, TNF-α, IL-6 and ICAM), fibrosis (α-SMA and TNFβ) and oxidative stress (NADPH-oxidase 2/4, CYP2E1 and antioxidant enzymes). These results suggest that TSG may be a promising candidate for preventing and treating the progression of NASH. MDPI 2019-04-01 /pmc/articles/PMC6479705/ /pubmed/30939745 http://dx.doi.org/10.3390/ijms20071617 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xu, Jin
Peng, Yi
Zeng, Yi
Hua, Yi-qiao
Xu, Xiao-le
2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms
title 2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms
title_full 2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms
title_fullStr 2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms
title_full_unstemmed 2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms
title_short 2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d Glycoside Attenuates Age- and Diet-Associated Non-Alcoholic Steatohepatitis and Atherosclerosis in LDL Receptor Knockout Mice and Its Possible Mechanisms
title_sort 2, 3, 4′, 5-tetrahydroxystilbene-2-0-β-d glycoside attenuates age- and diet-associated non-alcoholic steatohepatitis and atherosclerosis in ldl receptor knockout mice and its possible mechanisms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479705/
https://www.ncbi.nlm.nih.gov/pubmed/30939745
http://dx.doi.org/10.3390/ijms20071617
work_keys_str_mv AT xujin 2345tetrahydroxystilbene20bdglycosideattenuatesageanddietassociatednonalcoholicsteatohepatitisandatherosclerosisinldlreceptorknockoutmiceanditspossiblemechanisms
AT pengyi 2345tetrahydroxystilbene20bdglycosideattenuatesageanddietassociatednonalcoholicsteatohepatitisandatherosclerosisinldlreceptorknockoutmiceanditspossiblemechanisms
AT zengyi 2345tetrahydroxystilbene20bdglycosideattenuatesageanddietassociatednonalcoholicsteatohepatitisandatherosclerosisinldlreceptorknockoutmiceanditspossiblemechanisms
AT huayiqiao 2345tetrahydroxystilbene20bdglycosideattenuatesageanddietassociatednonalcoholicsteatohepatitisandatherosclerosisinldlreceptorknockoutmiceanditspossiblemechanisms
AT xuxiaole 2345tetrahydroxystilbene20bdglycosideattenuatesageanddietassociatednonalcoholicsteatohepatitisandatherosclerosisinldlreceptorknockoutmiceanditspossiblemechanisms